HUE056419T2 - Vilanterol trifenatát amorf formája, és eljárások ennek elkészítésére - Google Patents
Vilanterol trifenatát amorf formája, és eljárások ennek elkészítéséreInfo
- Publication number
- HUE056419T2 HUE056419T2 HUE18752193A HUE18752193A HUE056419T2 HU E056419 T2 HUE056419 T2 HU E056419T2 HU E18752193 A HUE18752193 A HU E18752193A HU E18752193 A HUE18752193 A HU E18752193A HU E056419 T2 HUE056419 T2 HU E056419T2
- Authority
- HU
- Hungary
- Prior art keywords
- processes
- preparation
- amorphous form
- vilanterol trifenatate
- trifenatate
- Prior art date
Links
- 229960002282 vilanterol trifenatate Drugs 0.000 title 1
- KLOLZALDXGTNQE-JIDHJSLPSA-N vilanterol trifenate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)O)C1=CC=CC=C1.C1=C(O)C(CO)=CC([C@@H](O)CNCCCCCCOCCOCC=2C(=CC=CC=2Cl)Cl)=C1 KLOLZALDXGTNQE-JIDHJSLPSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT110209A PT110209B (pt) | 2017-07-19 | 2017-07-19 | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
| PT2017110209 | 2017-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE056419T2 true HUE056419T2 (hu) | 2022-02-28 |
Family
ID=63143265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18752193A HUE056419T2 (hu) | 2017-07-19 | 2018-07-09 | Vilanterol trifenatát amorf formája, és eljárások ennek elkészítésére |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11414374B2 (hu) |
| EP (2) | EP3652148B1 (hu) |
| JP (2) | JP2020528057A (hu) |
| KR (2) | KR102572035B1 (hu) |
| CN (3) | CN115819257A (hu) |
| AU (2) | AU2018303782B9 (hu) |
| BR (1) | BR112020001171A2 (hu) |
| CA (2) | CA3070043A1 (hu) |
| DK (1) | DK3652148T3 (hu) |
| ES (1) | ES2899367T3 (hu) |
| HU (1) | HUE056419T2 (hu) |
| IL (3) | IL272109B2 (hu) |
| MX (1) | MX2022013014A (hu) |
| PL (1) | PL3652148T3 (hu) |
| PT (1) | PT110209B (hu) |
| WO (2) | WO2019016511A2 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT110209B (pt) | 2017-07-19 | 2021-05-17 | Hovione Farm Sa | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
| EP4013398A4 (en) * | 2019-08-16 | 2023-12-27 | Melody Healthcare Pvt. Ltd. | IMPROVED METHOD FOR PRODUCING VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
| CN114441677B (zh) * | 2022-01-25 | 2024-06-11 | 上海方予健康医药科技有限公司 | 一种同时检测三苯乙酸维兰特罗多种基因杂质的方法 |
| CN116199590A (zh) * | 2022-12-26 | 2023-06-02 | 湖北美林药业有限公司 | 一种盐酸多巴酚丁胺及其注射剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2458534C (en) | 2001-09-14 | 2011-11-01 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
| WO2014041565A2 (en) | 2012-09-13 | 2014-03-20 | Laurus Labs Private Limited | An improved process for the preparation of vilanterol and intermediates thereof |
| US10987363B2 (en) | 2014-05-28 | 2021-04-27 | Glaxosmithkline Intellectual Property Development Limited | Fluticasone furoate in the treatment of COPD |
| WO2017001907A1 (en) * | 2015-06-29 | 2017-01-05 | Teva Pharmaceuticals International Gmbh | Biocatalytic processes for the preparation of vilanterol |
| PT110209B (pt) | 2017-07-19 | 2021-05-17 | Hovione Farm Sa | Formas polimórficas de trifenatato de vilanterol e processos para a preparação das mesmas. |
-
2017
- 2017-07-19 PT PT110209A patent/PT110209B/pt active IP Right Grant
-
2018
- 2018-07-09 DK DK18752193.5T patent/DK3652148T3/da active
- 2018-07-09 CN CN202211471062.1A patent/CN115819257A/zh active Pending
- 2018-07-09 WO PCT/GB2018/051939 patent/WO2019016511A2/en unknown
- 2018-07-09 CN CN201880060197.4A patent/CN111094235A/zh active Pending
- 2018-07-09 IL IL272109A patent/IL272109B2/en unknown
- 2018-07-09 CA CA3070043A patent/CA3070043A1/en active Pending
- 2018-07-09 PL PL18752193T patent/PL3652148T3/pl unknown
- 2018-07-09 CA CA3069869A patent/CA3069869A1/en active Pending
- 2018-07-09 KR KR1020207004628A patent/KR102572035B1/ko active IP Right Grant
- 2018-07-09 IL IL298421A patent/IL298421A/en unknown
- 2018-07-09 HU HUE18752193A patent/HUE056419T2/hu unknown
- 2018-07-09 CN CN201880060726.0A patent/CN111108091B/zh active Active
- 2018-07-09 EP EP18752193.5A patent/EP3652148B1/en active Active
- 2018-07-09 JP JP2020502459A patent/JP2020528057A/ja active Pending
- 2018-07-09 WO PCT/GB2018/051940 patent/WO2019016512A1/en active Search and Examination
- 2018-07-09 BR BR112020001171-1A patent/BR112020001171A2/pt active Search and Examination
- 2018-07-09 EP EP18752192.7A patent/EP3655386A2/en active Pending
- 2018-07-09 ES ES18752193T patent/ES2899367T3/es active Active
- 2018-07-09 US US16/631,685 patent/US11414374B2/en active Active
- 2018-07-09 AU AU2018303782A patent/AU2018303782B9/en active Active
- 2018-07-09 US US16/631,683 patent/US11434194B2/en active Active
- 2018-07-09 AU AU2018303293A patent/AU2018303293B2/en active Active
- 2018-07-09 KR KR1020207004626A patent/KR20200030106A/ko not_active Application Discontinuation
-
2020
- 2020-01-15 MX MX2022013014A patent/MX2022013014A/es unknown
- 2020-01-17 IL IL272108A patent/IL272108A/en unknown
-
2023
- 2023-05-08 JP JP2023076831A patent/JP2023103328A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268406A (en) | Preparations and methods for treating hemoglobin diseases | |
| ZA202000157B (en) | Antiproliferative compounds and methods of use thereof | |
| HK1258205A1 (zh) | 用於治療血紅蛋白病的組合物和方法 | |
| IL265048A (en) | Distributed systems for efficient production and use of bacteria-based preparations | |
| PT3580219T (pt) | Processo para a preparação de remimazolam e formas de estado sólido de sais de remimazolam | |
| ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
| IL261414B (en) | Solid state forms of venetoclax and processes for preparation of venetoclax | |
| ZA201808411B (en) | Container and method of manufacturing the same | |
| IL272109A (en) | Amorphous configuration of vilantrol tripentate and processes for its preparation | |
| GB201519128D0 (en) | Solid forms and methods of preparing the same | |
| ZA202003590B (en) | Process for the preparation of opicapone and intermediates thereof | |
| HUE062956T2 (hu) | Eljárások niraparib és köztitermékei elõállítására | |
| IL262405A (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
| EP3285789A4 (en) | PLANT EXTRACTS FOR THE TREATMENT OF OVERWEIGHT AND ADIPOSITAS | |
| IL264403A (en) | Vortioxetine analogue and use and preparation thereof | |
| GB201613244D0 (en) | Powder and process | |
| HUE051536T2 (hu) | Eljárás 4-aminoindán-származékok és rokon amidoindán-amidok elõállítására | |
| ZA202002073B (en) | Lactate powder and method for the preparation thereof | |
| ZA202001062B (en) | Devices and methods for the preparation of a nutritional formula | |
| GB2548342B (en) | A novel form of amicarbazone, a process for its preparation and use of the same | |
| PL3551687T3 (pl) | Sposób wytwarzania kompozycji stabilizatora i wytworzona tym sposobem kompozycja stabilizatora | |
| EP3542143C0 (en) | RHEOMETER AND METHOD OF USE THEREOF | |
| GB201613243D0 (en) | Powder and process | |
| IL272837A (en) | A process for preparing tubolysins and their intermediates | |
| EP3638219C0 (en) | COMPOSITION CONTAINING TERPINEN-4-OL FOR THE TREATMENT OF DEMODICOSE |